Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 3
2005 1
2006 4
2007 8
2008 4
2009 15
2010 31
2011 20
2012 21
2013 23
2014 26
2015 13
2016 10
2017 6
2018 7
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

161 results

Results by year

Filters applied: . Clear all
Page 1
Genistein treatment duration effects biomarkers of cell motility in human prostate.
Zhang H, Gordon R, Li W, Yang X, Pattanayak A, Fowler G, Zhang L, Catalona WJ, Ding Y, Xu L, Huang X, Jovanovic B, Kelly DL, Jiang H, Bergan R. Zhang H, et al. PLoS One. 2019 Mar 27;14(3):e0214078. doi: 10.1371/journal.pone.0214078. eCollection 2019. PLoS One. 2019. PMID: 30917169 Free PMC article. Clinical Trial.
Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors.
Nettey OS, Walker AJ, Keeter MK, Singal A, Nugooru A, Martin IK, Ruden M, Gogana P, Dixon MA, Osuma T, Hollowell CMP, Sharifi R, Sekosan M, Yang X, Catalona WJ, Kajdacsy-Balla A, Macias V, Kittles RA, Murphy AB. Nettey OS, et al. Urol Oncol. 2018 Nov;36(11):501.e1-501.e8. doi: 10.1016/j.urolonc.2018.06.011. Epub 2018 Sep 17. Urol Oncol. 2018. PMID: 30236853 Free PMC article.
Precision therapeutic targeting of human cancer cell motility.
Xu L, Gordon R, Farmer R, Pattanayak A, Binkowski A, Huang X, Avram M, Krishna S, Voll E, Pavese J, Chavez J, Bruce J, Mazar A, Nibbs A, Anderson W, Li L, Jovanovic B, Pruell S, Valsecchi M, Francia G, Betori R, Scheidt K, Bergan R. Xu L, et al. Nat Commun. 2018 Jun 22;9(1):2454. doi: 10.1038/s41467-018-04465-5. Nat Commun. 2018. PMID: 29934502 Free PMC article.
IL-33 in Tumor Immunity: Nothing to Sneeze At.
Dominguez D, Zhang Y, Zhang B. Dominguez D, et al. Crit Rev Immunol. 2018;38(6):453-470. doi: 10.1615/CritRevImmunol.2018026335. Crit Rev Immunol. 2018. PMID: 31002600 Free PMC article. Review.
Efficacy Against Human Prostate Cancer by Prostate-specific Membrane Antigen-specific, Transforming Growth Factor-β Insensitive Genetically Targeted CD8+ T-cells Derived from Patients with Metastatic Castrate-resistant Disease.
Zhang Q, Helfand BT, Carneiro BA, Qin W, Yang XJ, Lee C, Zhang W, Giles FJ, Cristofanilli M, Kuzel TM. Zhang Q, et al. Eur Urol. 2018 May;73(5):648-652. doi: 10.1016/j.eururo.2017.12.008. Epub 2017 Dec 21. Eur Urol. 2018. PMID: 29275833 Free PMC article. Review.
Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.
Pascal LE, Masoodi KZ, Liu J, Qiu X, Song Q, Wang Y, Zang Y, Yang T, Wang Y, Rigatti LH, Chandran U, Colli LM, Vencio RZN, Lu Y, Zhang J, Wang Z. Pascal LE, et al. J Endocrinol. 2017 Nov;235(2):123-136. doi: 10.1530/JOE-17-0112. J Endocrinol. 2017. PMID: 28870994 Free PMC article.
161 results